3D-QSAR, DOCKING STUDY, PHARMACOPHORE MODELING AND ADMET PREDICTION OF 2-AMINO-PYRAZOLOPYRIDINE DERIVATIVES AS POLO-LIKE KINASE 1 INHIBITORS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 8
Abstract
Objective: The polo-like kinase 1 (plk1) plays important roles in the regulation of mitotic progression, including mitotic entry, spindle formation, chromosome segregation and cytokinesis. Thus, plk1 is considered as a good target for chemotherapeutic intervention. The main objectives of this research were to in silico screen the 2-amino-pyrazolopyridine derivatives as plk1 inhibitors and develop pharmacophore for enhanced activity.Methods: The three-dimensional quantitative structure–activity relationship (3D-QSAR), docking and pharmacophore identification studies on 2-amino-pyrazolopyridine derivatives as plk1 inhibitors have been carried out using V Life MDS 4.3 software. The stepwise 3D-QSAR kNN-MFA method was applied to derive QSAR model. Also, ADMET prediction was performed using FAF Drugs 2 which runs on Linux OS.Results: The information rendered by 3D-QSAR models may lead to a better understanding and designing of novel plk1 inhibitor molecules. The molecular docking analysis was carried out to better understand the interactions between plk1 enzyme and inhibitors in this series. Hydrophobic and hydrogen bond interactions lead to identification of active binding sites. The results of pharmacophore studies showed that hydrogen bond accepters, aromatic and aliphatic centers are the important features for polo-like kinase 1 inhibitor activity. ADMET prediction of these compounds showed good drug like properties.Conclusion: The combination of the 3D-QSAR, docking, pharmacophore modeling and ADMET prediction is an important tool in understanding the structural requirements for design of novel, potent and selective plk1 inhibitors and can be employed to design new  drug discovery and can be used for derivatives of 2-amino-pyrazolopyridines with specific plk1 inhibitory activity.Â
Authors and Affiliations
Jaiprakash Sangshetti, Firoz A. Kalam Khan, Yasar Q. Qazi, Manoj G. Damale, Zahid Zaheer
FORMULATION AND EVALUATION OF MELOXICAM LIQUISOLID COMPACT
Objective: The aim of the present research was to improve dissolution of poorly soluble meloxicam a BCS (Biopharmaceutical Classification System) Class-II drug by utilizing liquisolid technique. Different liquisolid (LS)...
COMPUTATIONAL INTERACTION OF ENTOMOPATHOGENIC FUNGAL SECONDARY METABOLITES WITH PROTEINS INVOLVED IN HUMAN XENOBIOTIC DETOXIFICATION
Objective: Entomopathogenic fungi are rich source of secondary metabolites which posses both pharmacological and insecticidal activity. It is essential to assess metabolite toxicity of chemically diverse toxic metabolite...
SYNTHESIS, CHARACTERIZATION, DNA CLEAVAGE AND ANTIMICROBIAL ACTIVITIES OF SCHIFF BASE LIGAND DERIVED FROM 5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYHYDRAZIDE AND O-VANILLIN AND ITS METAL (II) COMPLEXES
Objective: The main objective of the present work was to synthesize a new Schiff base ligand 5-chloro-N'-(2-hydroxy-3-methoxybenzylidene)-3-phenyl-1H-indole-2-carbohydrazide and its Cu (II), Co (II), Ni (II) and Zn (II)...
METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF INDINAVIR IN CAPSULES BY RP-HPLC
Objective: To develop an accurate, precise and linear Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method and validate as per ICH guidelines for the quantitative estimation of Indinavir Sulphate (400mg...
THE PHARMACOLOGICAL EFFECT OF STILBENES ISOLATED FROM KANGAROO ISLAND PROPOLIS ON SIRT-1 ENZYME ACTIVITY
Objective: Resveratrol, a trihydroxystilbene, has been claimed to be a potent activator to SIRT-1 enzyme activity, which in turn could have a useful future application in the management of many chronic conditions such as...